Drug development Training and Courses
The training and courses offered by Kinesis Pharma have been developed as a spin-off from practical project experience. Moreover the team of trainers are all drug development experts themselves and being active as either regulatory affairs consultant, clinical development consultant, non-clinical consultant or CMC consultant. They are on top of trends in drug development and therefore very capable in transferring the state of the art knowledge. Kinesis Pharma training and courses facilitate in improving your performance in drug development. The courses can be given on-site at the premises of the clients.
COURSE: Pharmacokinetics in drug development
The objective of this course is to provide a general understanding of the principles of preclinical and clinical pharmacokinetics and its role in drug development. On completion of this course you will be familiar with pharmacokinetic concepts and the underlying physiological processes. You will be able to effectively interpret pharmacokinetic information and put it in the context of drug development. Please find here more information or go directly to the registration form.
COURSE: Introduction on Drug Development
After successfully providing drug development courses to Asia, the “Introduction to drug development” course, as developed by Kinesis Pharma, is now introduced in the Netherlands. The introduction course will be presented by consultants of Kinesis Pharma and integrates all relevant aspects of drug development. For more information, future dates and registration, please contact us.
COURSE: Early Stage Clinical Development
The objective of this course is to give an introduction in the field of early stage (Phase 1 and 2a) clinical development and at the same time provide you with some practical tools to manage early stage clinical trials. On completion of this interactive course you will be able to put your own role in perspective of the whole early stage clinical development process. With the acquired knowledge, you are better able to anticipate and thus provide a more efficient conduct of clinical development. Please contact us for more information.